IP Library Granted Patent US 7,022,869
Granted Patent B2
US 7,022,869 · App. 10/444,343 · Granted Apr 4, 2006

Methods of asymmetrically synthesizing enantiomers of casodex, its derivatives and intermediates thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,022,869
App. No.
10/444,343
Granted
Apr 4, 2006
Kind
B2
Abstract

Methods of synthesizing pure enantiomers of acylanalides such as Casodex® (bicalutamide) and its derivatives utilizing a compound having a ring structure that, when opened, provides a substituent having the structure of Formula I: wherein R 1 is alkyl or haloalkyl having up to 4 carbons; R 2 is alkyl having up to 6 carbon atoms; and R 3 is CH 2 OR 4 where R 4 is hydrogen or benzyl, C(O)CH 3 , or C(O)OR 5 where R 5 is hydrogen or alkyl; are disclosed.

Claims (33)

1. A method of asymmetrically synthesizing an enantiomer of an acylanilide or a derivative thereof comprising:

(a) contacting a compound having a ring structure, said compound having the structure of Formula IV:

wherein

R 1 is alkyl having up to 4 carbons;

R 2′ is alkylene having up to 6 carbon atoms;

R 9 is hydrogen, or straight, branched or cyclic alkyl;

R 10 is straight or branched alkyl, aryl, or R 11 X 3 4 , where R 11 is alkyl and X 4 is alkyl, halogen or aryl; and

X 3 is a leaving group;

wherein said compound of Formula IV, when opened, provides a substituent having the structure of Formula I:

wherein

R 1 is alkyl having up to 4 carbons;

R 2 is alkyl having up to 6 carbon atoms; and

R 3 is CH 2 OR 4 where R 4 is hydrogen or benzyl, C(O)CH 3 , or C(O)OR 5 where R 5 is hydrogen or alkyl;

with a compound having a structure of Formula II:

R 7 —R 6 —X 1 H  Formula II

wherein

R 6 is a direct link or alkylene having up to 6 carbon atoms;

R 7 is alkyl, alkenyl, hydroxyalkyl or cycloalkyl each of up to 6 carbons; or R 7 is phenyl which bears one, two or three substituents independently selected from hydrogen, halogen, nitro, carboxy, carbamoyl and cyano, and alkyl, alkoxy, alkanoyl, alkylthio, alkylsulphinyl, alkylsulphonyl, perfluoroalkyl, perfluoroalkylthio, perfluoroalkylsulphinyl, perfluoroalkylsulphonyl, alkoxycarbonyl and N-alkylcarbamoyl each of up to 4 carbon atoms, and phenyl, phenylthio, phenylsulphinyl and phenylsulphonyl; or R 7 is naphthyl; or R 7 is a 5- or 6-membered saturated or unsaturated heterocyclic which contains one, two or three heteroatoms selected from oxygen, nitrogen and sulfur, which heterocyclic may be a single ring or may be fused to a benzo-ring, and which heterocyclic is unsubstituted or bears one or two halogen, cyano or amino, or alkyl, alkoxy, alkylthio, alkylsulphinyl or alkylsulphonyl each of up to 4 carbon atoms, or oxy or hydroxy substituents, or which if sufficiently saturated may bear one or two oxo substituents; and

X 1 is oxygen, sulfur, sulphinyl (—SO—), sulphonyl (—SO 2 —), imino (—NH—) or alkylimino (—NR 8 —) where R 8 is alkyl having up to 6 carbon atoms;

under conditions sufficient to provide a compound having the structure of Formula III:

wherein X 2 is oxygen, sulfur, sulphinyl (—SO—), sulphonyl (—SO 2 —), imino (—NH—), oxidized imino alkylimino (—NR 8 —) where R 8 is alkyl having up to 6 carbon atoms, or oxidized alkylimino; and

(b) treating the compound of Formula III under conditions sufficient to provide a pure enantiomer of an acylanilide or a derivative thereof.

2. The method according to claim 1 , wherein step (a) comprises contacting the compound of Formula IV with the compound of Formula II under conditions sufficient to provide a compound having the structure of Formula V:

3. The method according to claim 2 further comprising treating a starting compound of citramalic acid under conditions sufficient to provide a compound having a structure of Formula IV, wherein the citramalic acid is (S)-citramalic acid, and wherein the pure enantiomer of an acylanilide is (R)-Casodex® (bicalutamide) or a derivative thereof.

4. The method according to claim 1 , wherein X 1 is sulfur, R 6 is a direct link, and R 7 is 4-fluorophenyl, and the compound of Formula II is 4-fluorobenzenethiol.

5. The method according to claim 1 , wherein step (b) comprises:

treating the compound of Formula III with a compound having the structure of Formula XIII:

wherein

R 13 is cyano, carbamoyl, nitro, fluoro, chloro, bromo, iodo, alkanoyl, alkylthio, alkylsulphinyl, alkylsulphonyl, perfluoroalkyl, perfluoroalkylthio, perfluoroalkylsulphinyl or perfluoroalkylsulphonyl each having up to 4 carbon atoms, or phenylthio, phenylsulphinyl or phenylsulphonyl;

R 14 is cyano, cabamoyl, nitro, fluoro, chloro, bromo or iodo, or alkanoyl, alkylthio, alkylsulphinyl, alkylsulphonyl, perfluoroalkyl, perfluoroalkylthio, perfluoroalkylsulphinyl or perfluoroalkylsulphonyl each of having up to 4 carbon atoms; or phenylthio, phenylsulphinyl or phenylsulphonyl; and

R 15 is hydrogen or halogen;

under conditions sufficient to provide a compound of Formula XIV:

wherein X 2 is oxygen, sulfur, sulphinyl (—SO—), sulphonyl (—SO 2 —), imino (—NH—), alkylimino (—NR 8 —) where R 8 is alkyl having up to 6 carbon atoms, or oxidized alkylimino.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 2, 2006
From: NOBEX CORPORATION
To: BIOCON LIMITED
Reel/Frame 017555/0904 →
SECURITY AGREEMENT Recorded Mar 9, 2006
From: NOBEX CORPORATION
To: BIOCON LIMITED
Reel/Frame 017649/0280 →